Doctor

We open our interview series with a very interesting clinical case, brought to us by Dr Silvio Zagari, which we think will capture the interest of both ophthalmologist colleagues and the web audience.

Our column "I'll tell you a story... " is inaugurated with an interview with Dr Silvio Zagari, an ophthalmologist who has made the saying "The more I like doing something,......

A complex or unusual case that you managed to solve: tell our magazine about it.

"I'll tell you a story...", our new column conceived with ophthalmologists and for ophthalmologists. Ophthalmologists will be protagonists in the first person. "I'll tell you a story..." will involve professionals from......

Ocular syphilis is quite rare, but can have a serious impact on the visual apparatus and, above all, is extremely difficult to diagnose correctly.

Syphilis is an infection caused by the spirochete bacterium Treponema pallidum and can have severe ocular manifestations, which can involve all the structures of the eye, leading to interstitial keratitis, chorioretinitis, retinitis,......

An entirely new approach to diagnosis, harnessing the power of increasingly complex and sophisticated algorithms capable of processing a huge amount of data

Artificial intelligence applied in medicine always gives rise to new and promising perspectives, especially in ophthalmology. Researchers at the University of Birmingham have, in fact, succeeded in developing, thanks to......

Promising results from phase 3 studies of the monoclonal antibody Faricimab, which according to the data already presented is effective in reducing macular oedema and allowing longer intravitreal administration intervals.

Retinal Vein Occlusions (RVO) are, after diabetic retinopathy, the most common retinal vascular disorder and affect over 28 million people worldwide, with......

A drug, still in clinical trials, opens up new perspectives for people suffering from this severe progressive maculopathy.

A new molecule, in clinical trials, is able to halt the progression of this severe hereditary maculopathy if administered from the earliest stages of the disease. The new molecule is gildeuretinol......

The year 2024 opens with good prospects for the treatment of antibiotic-resistant bacterial infections and the future of drug research.

A new class of antibiotics has been discovered that, both in laboratory and mouse experiments, has proved effective against Staphylococcus aureus strains resistant to......

Difficult to diagnose, but susceptible to early treatment Eyes that often become inflamed, in young patients, with many clinical signs of keratitis, but with a special feature: inflammation of the......